Overall Survival Benefits of First-Line Treatments for Asian Patients with Advanced Epidermal Growth Factor Receptor-Mutated NSCLC Harboring Exon 19 Deletion: A Systematic Review and Network Meta-Analysis

Overall Survival Benefits of First-Line Treatments for Asian Patients with Advanced Epidermal Growth Factor Receptor-Mutated NSCLC Harboring Exon 19 Deletion: A Systematic Review and Network Meta-Analysis

(1) Background: Randomized controlled trials (RCTs) have explored various primary treatments for individuals diagnosed as having later-stage epidermal growth factor receptor (EGFR)-mutated non-small-cell lung cancer. Nevertheless, the extent to which such treatments are efficacious, particularly wit...

Full description

Bibliographic Details
Main Authors:	Sik-Kwan Chan, Horace Cheuk-Wai Choi, Victor Ho-Fun Lee
Format:	Article
Language:	English
Published:	MDPI AG 2022-07-01
Series:	Cancers
Subjects:	non-small-cell lung cancer epidermal growth factor receptor exon 19 deletion tyrosine kinase inhibitors Asian
Online Access:	https://www.mdpi.com/2072-6694/14/14/3362

Similar Items

Overall Survival Benefits of First-Line Treatments for Asian Patients With Advanced EGFR-Mutated NSCLC Harboring L858R Mutation: A Systematic Review and Network Meta-Analysis
by: Sik-Kwan Chan, PhD, et al.
Published: (2022-05-01)

Novel Exon-Skipping Therapeutic Approach for the DMD Gene Based on Asymptomatic Deletions of Exon 49
by: Mario Abaji, et al.
Published: (2022-07-01)

Investigating the Implications of CFTR Exon Skipping Using a Cftr Exon 9 Deleted Mouse Model
by: Kelly M. Martinovich, et al.
Published: (2022-03-01)

The exon 19-deleted EGFR undergoes ubiquitylation-mediated endocytic degradation via dynamin activity-dependent and -independent mechanisms
by: Taishu Wang, et al.
Published: (2018-07-01)

Clinical outcomes of advanced NSCLC patients with different EGFR exon 19 deletion subtypes treated with first‐line tyrosine kinase inhibitors: A single‐center ambispective cohort study
by: Yangchun Gu, et al.
Published: (2023-11-01)

Patients harboring uncommon EGFR exon 19 deletion-insertion mutations respond well to first-generation EGFR inhibitors and osimeritinib upon acquisition of T790M
by: Yurong Wang, et al.
Published: (2021-11-01)

A Novel Insertion Mutation on Exon 20 of Epidermal Growth Factor Receptor, Conferring Resistance to Erlotinib
by: Nawazish A. Khan, et al.
Published: (2014-07-01)

RELAY, Erlotinib Plus Ramucirumab in Untreated, EGFR-Mutated, Metastatic NSCLC: Outcomes by EGFR Exon 19 Deletion Variants
by: Kazumi Nishino, MD, PhD, et al.
Published: (2024-02-01)

Mutations in the exons of epidermal growth factor receptor gene are associated with clinicopathological features of lung cancer
by: Yanhui Wan, et al.
Published: (2020-10-01)

Exons deletion of CNKSR2 gene identified in X-linked syndromic intellectual disability
by: Mei Daoqi, et al.
Published: (2020-04-01)

EGFR T751_I759delinsN Mutation in Exon19 Detected by NGS but Not by Real-Time PCR in a Heavily-Treated Patient with NSCLC
by: Zi-Ting Chang, et al.
Published: (2022-11-01)

Advances in Treatment of Non-small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations
by: Xue YANG, et al.
Published: (2022-05-01)

Exons 1–3 deletion in FLCN is associated with increased risk of pneumothorax in Chinese patients with Birt-Hogg-Dubé syndrome
by: Yue Wang, et al.
Published: (2023-05-01)

The effect of a single SMARCA4 exon deletion on RNA splicing: Implications for variant classification
by: Anna Byrjalsen, et al.
Published: (2023-10-01)

Rechallenge with EGFR-TKI after failure of immunotherapy is considered an effective treatment for advanced lung adenocarcinoma patients with EGFR exon 19 deletion: a case report
by: Shubin Chen, et al.
Published: (2023-06-01)

Specific HER2 Exon 20 Gly776 Deletion-Insertions in Non-Small Cell Lung Cancer: Structural Analysis and Sensitivity to HER2-Targeted Tyrosine Kinase Inhibitors
by: Guangjian Yang, et al.
Published: (2022-03-01)

Concurrent TP53 mutations predict poor outcomes of EGFR-TKI treatments in Chinese patients with advanced NSCLC
by: Hou H, et al.
Published: (2019-06-01)

Amivantamab-Vmjw: A Novel Treatment for Patients with NSCLC Harboring EGFR Exon 20 Insertion Mutation after Progression on Platinum-Based Chemotherapy
by: Vishal Shah, et al.
Published: (2023-03-01)

The Exon 3-Deleted Growth Hormone Receptor (d3GHR) Polymorphism—A Favorable Backdoor Mechanism for the GHR Function
by: Ghadeer Falah, et al.
Published: (2023-09-01)

Case Report: Durable therapy response to Osimertinib in rare EGFR Exon 18 mutated NSCLC
by: Michael Cekay, et al.
Published: (2023-08-01)

Real-World Response and Outcomes in Patients With NSCLC With EGFR Exon 20 Insertion Mutations
by: Sai-Hong Ignatius Ou, MD, et al.
Published: (2023-10-01)

Epidermal Growth Factor Receptor immunohistochemical expression in hepatocellular carcinoma without Epidermal Growth Factor Receptor exons 18–21 mutations
by: Nikolova Dafina, et al.
Published: (2022-09-01)

Non-small cell lung cancer cells with uncommon EGFR exon 19delins variants respond poorly to third-generation EGFR inhibitors
by: Zhiqin Lu, et al.
Published: (2024-01-01)

Molecular Epidemiology and Treatment Patterns of Patients With EGFR Exon 20-Mutant NSCLC in the Precision Oncology Era: The European EXOTIC Registry
by: Giannis Mountzios, MD, PhD, et al.
Published: (2023-01-01)

Clinicopathological Features and Significance of Epidermal Growth Factor Receptor Mutation in Surgically Resected Early-Stage Lung Adenocarcinoma
by: Chao-Wen Lu, et al.
Published: (2023-01-01)

Clinical outcomes of EGFR-TKI treatment and genetic heterogeneity in lung adenocarcinoma patients with EGFR mutations on exons 19 and 21
by: Jiang-Yong Yu, et al.
Published: (2016-03-01)

Differential efficacy of tyrosine kinase inhibitors according to the types of EGFR mutations and agents in non-small cell lung cancer: a real-world study
by: Tae-Hwan Kim, et al.
Published: (2024-01-01)

Studies and Progress of EGFR exon 20 Insertion Mutation in Non-small Cell Lung Cancer
by: Wensheng ZHOU, et al.
Published: (2020-02-01)

EGFR exon 19‐deletion aberrantly regulate ERCC1 expression that may partly impaired DNA damage repair ability in non‐small cell lung cancer
by: Linlin Zhang, et al.
Published: (2020-02-01)

Novel Partial Exon 51 Deletion in the Duchenne Muscular Dystrophy Gene Identified via Whole Exome Sequencing and Long-Read Whole-Genome Sequencing
by: Qianqian Li, et al.
Published: (2021-11-01)

GENETIC POLYMORPHISMS OF HLA-G GENE IN RHEUMATOID ARTHRITIS
by: Tabarek A. A., et al.
Published: (2023-04-01)

Efficacy of erlotinib in NSCLC harboring rare EGFR extracellular domain mutation (T263P) and common mutations: Case report and literature review
by: Qian Wang, et al.
Published: (2022-09-01)

Comparison of epidermal growth factor receptor tyrosine kinase inhibitors for patients with lung adenocarcinoma harboring different epidermal growth factor receptor mutation types
by: Sojung Park, et al.
Published: (2021-01-01)

Cabozantinib Response in a Patient With NSCLC Harboring Both MET Exon 14 Skipping Mutation and Secondary RET Fusion: A Case Report
by: Carlos Torrado, MD, et al.
Published: (2024-04-01)

EGFR Testing Patterns and Detection of EGFR Exon 20 Insertions in the United States
by: Huamao M. Lin, PhD, et al.
Published: (2022-03-01)

Advances in the Treatment of EGFR Exon 20ins Mutant NSCLC
by: Meiyi XU, et al.
Published: (2023-02-01)

Chinese Expert Consensus on Non-small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations (2023 Edition)
by: Chinese Society of Clinical Oncology (CSCO) Non-small Cell Lung Cancer Committee
Published: (2023-05-01)

Case report: Compound heterozygosity in PKLR gene with a large exon deletion and a novel rare p.Gly536Asp variant as a cause of severe pyruvate kinase deficiency
by: Minsun Kim, et al.
Published: (2022-12-01)

Prevention of early-onset cardiomyopathy in Dmd exon 52–54 deletion mice by CRISPR-Cas9-mediated exon skipping
by: Matthew Rok, et al.
Published: (2023-09-01)

Clinical implications of cytosine deletion of exon 5 of P53 gene in non small cell lung cancer patients
by: Rashid Mir, et al.
Published: (2016-01-01)